Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
108M
-
Number of holders
-
879
-
Total shares
-
89.5M
-
Shares change
-
-1.45M
-
Total reported value, excl. options
-
$43.2B
-
Value change
-
-$836M
-
Put/Call ratio
-
1.33
-
Number of buys
-
456
-
Number of sells
-
-406
-
Price
-
$483.11
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2020
921 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2020.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 879 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.5M shares
of 108M outstanding shares and own 83.04% of the company stock.
Largest 10 shareholders include FMR LLC (11.5M shares), BlackRock Inc. (9.78M shares), VANGUARD GROUP INC (7.93M shares), Capital World Investors (6.95M shares), STATE STREET CORP (4.69M shares), WELLINGTON MANAGEMENT GROUP LLP (3.63M shares), LOOMIS SAYLES & CO L P (2.96M shares), JPMORGAN CHASE & CO (2.31M shares), POLEN CAPITAL MANAGEMENT LLC (2M shares), and ALLIANCEBERNSTEIN L.P. (1.76M shares).
This table shows the top 879 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.